Insulin Resistance after Fontan Palliation
Pediatric Cardiology · 2025
DOI: 10.1007/s00246-024-03663-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Cardiology, 2025. Verfasst von Erin V Shea und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Cardiology, Duke University Medical Center, Durham, NC, USA. Hauptthemen laut MEDLINE: Fontan Procedure, Insulin Resistance, Heart Defects, Congenital. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Patients with a single ventricle heart who had Fontan palliation (S/P Fontan) are at increased risk for acquired morbidity. Insulin resistance (IR) is a predictor of cardiac morbidity and mortality. A single-center, cross-sectional study using S/P Fontan and controls was designed to assess IR S/P Fontan. Group comparisons were made in IR via the Quantitative Insulin Index (QUICKI) and the natural log-transformed homeostasis model assessment, ln (HOMA-IR), without/with adjusting for age. A total of 89 patients (59 Fontan and 30 controls) were included. Fontan patients showed a significant decrease in QUICKI (0.34 ± 0.03 vs 0.37 ± 0.02) and an elevation of ln (HOMA-IR) (0.82 ± 0.62 vs 0.24 ± 0.44) compared to controls (both p < 0.0001); this remained significant even adjusting for age. With older age, there was a significant, progressive decrease in QUICKI (p = 0.01) and an increase in ln (HOMA-IR) (p = 0.02) S/P Fontan. Analysis excluding Fontan patients with obesity still showed a significant reduction of QUICKI and an elevation of ln (HOMA-IR) in Fontan patients compared to controls when adjusting for age (both p < 0.05). Using QUICKI, IR was present in 41 (69.5%) Fontan patients vs. 3 (10%) controls (p < 0.0001) and using HOMA-IR, IR was present in 32 (54.2%) vs 5 (16.7%) controls (p = 0.001). Fontan patients had significantly more IR compared to controls and the prevalence of IR increases with age. Since IR is known to correlate with long-term morbidity and mortality and can be ameliorated by therapies, we believe it is critical that IR be identified as early as possible in Fontan patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Cardiology, Duke University Medical Center, Durham, NC, USA.
- Division of Pediatric Cardiology, University of Michigan Congenital Heart Center, C.S. Mott Children's Hospital, 1540 East Medical Center Drive, Ann Arbor, MI, 48109-420, USA.
- Division of Pediatric Cardiology, University of Michigan Congenital Heart Center, C.S. Mott Children's Hospital, 1540 East Medical Center Drive, Ann Arbor, MI, 48109-420, USA. rocchini@med.umich.edu.
Zitieren
APA
Shea, E. V., Yu, S., Schumacher, K. R., Lowery, R., Doman, T., & Rocchini, A. P. (2025). Insulin Resistance after Fontan Palliation. Pediatric Cardiology. https://doi.org/10.1007/s00246-024-03663-x
Vancouver
Shea EV, Yu S, Schumacher KR, Lowery R, Doman T, Rocchini AP. Insulin Resistance after Fontan Palliation. Pediatric Cardiology. 2025. doi:10.1007/s00246-024-03663-x
BibTeX
@article{Shea2025,
author = {Shea, Erin V and Yu, Sunkyung and Schumacher, Kurt R and Lowery, Ray and Doman, Tammy and Rocchini, Albert P},
title = {Insulin Resistance after Fontan Palliation},
journal = {Pediatric Cardiology},
year = {2025},
doi = {10.1007/s00246-024-03663-x}
}
EUVIMED